Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juillière Y.

J Am Coll Cardiol. 2007 Apr 24;49(16):1733-9. Epub 2007 Apr 2.

2.

BNP in hormone-guided treatment of heart failure.

Richards AM, Lainchbury JG, Nicholls MG, Troughton RW, Yandle TG.

Trends Endocrinol Metab. 2002 May-Jun;13(4):151-5. Review.

PMID:
11943558
3.

Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.

Kjaer A, Hesse B.

Clin Physiol. 2001 Nov;21(6):661-72. Review.

PMID:
11722473
4.

[Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].

Krüger S, Hoffmann R, Graf J, Janssens U, Hanrath P.

Med Klin (Munich). 2003 Oct 15;98(10):562-7. Review. German.

PMID:
14586510
5.

[Brain natriuretic peptide].

Tsutamoto T, Horie M.

Rinsho Byori. 2004 Aug;52(8):655-68. Review. Japanese.

PMID:
15478621
6.

The role of BNP testing in heart failure.

Doust J, Lehman R, Glasziou P.

Am Fam Physician. 2006 Dec 1;74(11):1893-8. Review.

7.

Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts.

Latini R, Masson S, de Angelis N, Anand I.

J Card Fail. 2002 Oct;8(5):288-99. Review.

PMID:
12411979
8.

Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.

Le Jemtel TH, Padeletti M, Jelic S.

J Am Coll Cardiol. 2007 Jan 16;49(2):171-80. Epub 2006 Dec 29. Review.

9.

Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve?

Doba N, Tomiyama H, Nakayama T.

Drugs Aging. 1999 Mar;14(3):153-63. Review.

PMID:
10220102
10.

BNP assays: predicting the future of CHF patients.

Kinkade E, Frazier SK.

Nurse Pract. 2006 Dec;31(12):36-41. Review. No abstract available.

PMID:
17149134
11.

Cardiac troponin levels in heart failure.

Potluri S, Ventura HO, Mulumudi M, Mehra MR.

Cardiol Rev. 2004 Jan-Feb;12(1):21-5. Review.

PMID:
14667259
12.

B-type natriuretic peptide measurement in heart failure.

Spevack DM, Schwartzbard A.

Clin Cardiol. 2004 Sep;27(9):489-94. Review.

13.

Brain natriuretic peptide and optimal management of heart failure.

Li N, Wang JA.

J Zhejiang Univ Sci B. 2005 Sep;6(9):877-84. Review.

14.

Update in the approach to and management of heart failure.

Gelow JM, Fang JC.

South Med J. 2006 Dec;99(12):1346-55; quiz 1356-7, 1384. Review.

PMID:
17233191
15.

Implications of CIBIS III: a commentary.

Willenheimer R.

J Renin Angiotensin Aldosterone Syst. 2005 Dec;6(3):115-20. Review.

PMID:
16525941
16.

Problems solved and lives saved? Chronic heart failure.

McMurray J, Francis M.

Br J Clin Pract. 1994 Jan-Feb;48(1):29-36. Review.

PMID:
8179979
17.

Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies.

Battaglia M, Pewsner D, Jüni P, Egger M, Bucher HC, Bachmann LM.

Arch Intern Med. 2006 May 22;166(10):1073-80. Review.

PMID:
16717169
18.

Treatment of early heart failure: an ACEI or a beta-blocker first?

Willenheimer R.

Expert Opin Investig Drugs. 2006 May;15(5):487-93. Review.

PMID:
16634687
19.
20.

[The diuretic in chronic cardiac failure: a clumsy partner].

Rocca C.

Arch Mal Coeur Vaiss. 2006 Jun;99(6):599-606. Review. French.

PMID:
16878721

Supplemental Content

Support Center